Company 3Legs Resources plc London S.E.
Equities
IM00B52P5P72
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- GBX | - |
|
2019 | SalvaRx Evaluates Takeover Opportunities | CI |
2019 | Salvarx Group plc Reports Earnings Results for the Half Year Ended June 30, 2019 | CI |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Denham Eke
DFI | Director of Finance/CFO | 73 | 19-01-07 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Jim Mellon
CHM | Chairman | 68 | - |
Peter Redmond
BRD | Director/Board Member | 76 | - |
Gregory Bailey
FOU | Founder | 68 | 06-12-31 |
Denham Eke
DFI | Director of Finance/CFO | 73 | 19-01-07 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 36,699,642 | 7,460,186 ( 20.33 %) | 0 | 20.33 % |
Company contact information
![address 3Legs Resources plc](https://cdn.zonebourse.com/static/address/8149126.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+20.95% | 127B | |
+23.00% | 117B | |
+24.66% | 27.77B | |
-19.75% | 20.44B | |
-15.15% | 16.62B | |
-16.56% | 15.92B | |
-46.65% | 14.94B | |
+11.19% | 14.74B | |
+57.74% | 14.38B |
- Stock Market
- Equities
- SALV Stock
- Stock
- Company 3Legs Resources plc